Exane Derivatives’s Aptiv APTV Stock Holding History

Exane Derivatives’s Portfolio APTV Stock Details APTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.07K	Sell	12 -1,104	-99%	-$113K	﹤0.01%	499
2022 Q1	$134K	Sell	1,116 -167	-13%	-$22.2K	0.04%	427
2021 Q4	$212K	Sell	1,283 -1,409	-52%	-$235K	0.05%	325
2021 Q3	$401K	Sell	2,692 -321	-11%	-$50K	0.1%	225
2021 Q2	$475K	Buy	3,013 +118	+4%	+$17.3K	0.11%	191
2021 Q1	$399K	Buy	2,895 +1,107	+62%	+$161K	0.11%	177
2020 Q4	$233K	Buy	1,788 +88	+5%	+$9.78K	0.07%	289
2020 Q3	$156K	Hold	1,700	–	–	0.05%	237
2020 Q2	$132K	Buy	+1,700	New	+$117K	0.04%	253
2017 Q3	–	Sell	-9	Closed	-$789	–	573
2017 Q2	$789	Sell	9 -49,300	-100%	-$4.11M	﹤0.01%	489
2017 Q1	$3.97M	Buy	+49,309	New	+$3.7M	0.9%	25

Other funds holding APTV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Exane Derivatives's APTV Position: Q2 2022 in Review

Exane Derivatives reduced its Aptiv (APTV) stake by 99% in Q2 2022, selling an estimated $113K and leaving 12 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Exane Derivatives first reported a position in APTV in Q1 2017 and has held it in 11 quarters since. The position peaked at $3.97M in Q1 2017. 745 funds tracked by Wall St. Rank hold APTV as of Q2 2022.

Exane Derivatives held 12 shares of Aptiv worth $1.07K as of Q2 2022.
Exane Derivatives sold 1,104 Aptiv shares in Q2 2022, an estimated $113K.
Aptiv made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #499 holding.
Exane Derivatives first reported a position in Aptiv in Q1 2017 and has held it in 11 quarters since.
Exane Derivatives's Aptiv position peaked at $3.97M in Q1 2017.
745 funds tracked by Wall St. Rank held Aptiv as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.